AptarGroup, Inc. (ATR)
NYSE: ATR · Real-Time Price · USD
119.31
-0.03 (-0.03%)
Nov 18, 2025, 4:00 PM EST - Market closed
AptarGroup Market Cap
AptarGroup has a market cap or net worth of $7.83 billion as of November 18, 2025. Its market cap has decreased by -29.93% in one year.
Market Cap
7.83B
Enterprise Value
8.85B
1-Year Change
-29.93%
Ranking
Category
Stock Price
$119.31
Market Cap Chart
Since December 1, 1998, AptarGroup's market cap has increased from $1.03B to $7.83B, an increase of 657.09%. That is a compound annual growth rate of 7.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 7.83B | -25.09% |
| Dec 31, 2024 | 10.45B | 28.55% |
| Dec 29, 2023 | 8.13B | 13.26% |
| Dec 30, 2022 | 7.18B | -10.95% |
| Dec 31, 2021 | 8.06B | -9.00% |
| Dec 31, 2020 | 8.86B | 19.87% |
| Dec 31, 2019 | 7.39B | 25.09% |
| Dec 31, 2018 | 5.91B | 9.94% |
| Dec 29, 2017 | 5.37B | 16.72% |
| Dec 30, 2016 | 4.60B | 1.50% |
| Dec 31, 2015 | 4.54B | 4.86% |
| Dec 31, 2014 | 4.33B | -3.11% |
| Dec 31, 2013 | 4.47B | 40.89% |
| Dec 31, 2012 | 3.17B | -8.05% |
| Dec 30, 2011 | 3.45B | 8.03% |
| Dec 31, 2010 | 3.19B | 32.10% |
| Dec 31, 2009 | 2.42B | 1.53% |
| Dec 31, 2008 | 2.38B | -14.90% |
| Dec 31, 2007 | 2.80B | 37.43% |
| Dec 29, 2006 | 2.03B | 11.48% |
| Dec 30, 2005 | 1.82B | -3.31% |
| Dec 31, 2004 | 1.89B | 33.33% |
| Dec 31, 2003 | 1.42B | 26.09% |
| Dec 31, 2002 | 1.12B | -10.61% |
| Dec 31, 2001 | 1.26B | 20.14% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 922.29B |
| Johnson & Johnson | 481.86B |
| AbbVie | 413.34B |
| UnitedHealth Group | 284.05B |
| AstraZeneca | 276.37B |
| Novartis AG | 244.75B |
| Merck & Co. | 239.34B |
| Abbott Laboratories | 226.05B |